Suppressing testosterone levels in male athletes isn’t enough to eliminate their natural advantages over female athletes, according to a recently published paper in the Journal of Medical Ethics.
The paper’s findings contradict congressional Democrats’ claim that male athletes who identify as transgender don’t have an inherent advantage over their female competitors.
The paper, “Transwomen in elite sport: scientific and ethical considerations,” concluded that male athletes who identify as transgender women have an “intolerable” advantage over their female competitors.
The authors, two bioethics professors and a physiology professor, noted that “there is very little scientific evidence” to support the argument that “hormone therapy will mitigate the advantage transwomen may have in comparison with cis-women athletes.”
The authors cited research showing that “healthy young men did not lose significant muscle mass (or power) when their circulating testosterone levels were reduced to [below International Olympic Committee guidelines] for 20 weeks.”